Bill Snyder Archive — Page 44 of 121

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
April 14, 2021

Five land ASCI Young Physician-Scientist Awards

Five Vanderbilt University Medical Center faculty members have received Young Physician-Scientist Awards from the American Society of Clinical Investigation (ASCI), an elite honor society of physician-scientists.

Graphic with large white text reading “60 MINUTES” above a partial stopwatch on a red background.
April 12, 2021

VUMC team’s COVID-19 research featured on “60 Minutes”

James Crowe, MD, and members of his lab at Vanderbilt University Medical Center who have pioneered rapid development of monoclonal antibody treatments for life-threatening viral diseases including COVID-19, were featured Sunday on a CBS News 60 Minutes segment titled “The Last Pandemic.”

Benjamin Brown, left, Jens Meiler, PhD, Zhenfang Du, PhD, and colleagues are studying the functional consequences of genetic mutations and how those changes can drive cancerous growth.
April 8, 2021

Personalized Structural Biology aids cancer treatment decisions

Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level.

Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
April 6, 2021

U.S. government reserves supply of COVID-19 antibody cocktail discovered at VUMC

The U.S. government has reserved up to 700,000 doses of a monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca, officials have announced.

Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.
April 2, 2021

Investigational vaccine to be tested against COVID-19 variant

Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.

April 1, 2021

Novel way to neutralize Rift Valley Fever Virus

The discovery of monoclonal antibodies that neutralize Rift Valley Fever Virus — an emerging infection with pandemic potential — lays the foundation for future therapeutic antibody development.